Research Evidence on High-Fat Diet-Induced Prostate Cancer Development and Progression

por Narita, Shintaro, Nara, Taketoshi, Sato, Hiromi, Koizumi, Atsushi, Huang, Mingguo, Inoue, Takamitsu, Habuchi, Tomonori
Publicado 2019

Successful mammalian target of rapamycin inhibitor maintenance therapy following induction chemotherapy with gemcitabine and doxorubicin for metastatic sarcomatoid renal cell carci...

por NUMAKURA, KAZUYUKI, TSUCHIYA, NORIHIKO, AKIHAMA, SUSUMU, INOUE, TAKAMITSU, NARITA, SHINTARO, HUANG, MINGGUO, SATOH, SHIGERU, HABUCHI, TOMONORI
Publicado 2014

Macrophage inhibitory cytokine‐1 induced by a high‐fat diet promotes prostate cancer progression by stimulating tumor‐promoting cytokine production from tumor stromal cells

por Huang, Mingguo, Narita, Shintaro, Koizumi, Atsushi, Nara, Taketoshi, Numakura, Kazuyuki, Satoh, Shigeru, Nanjo, Hiroshi, Habuchi, Tomonori
Publicado 2021

Fatty acid binding protein 4 enhances prostate cancer progression by upregulating matrix metalloproteinases and stromal cell cytokine production

por Huang, Mingguo, Narita, Shintaro, Inoue, Takamitsu, Koizumi, Atsushi, Saito, Mitsuru, Tsuruta, Hiroshi, Numakura, Kazuyuki, Satoh, Shigeru, Nanjo, Hiroshi, Sasaki, Takehiko, Habuchi, Tomonori
Publicado 2017

Insulin-like growth factor-1 genotypes and haplotypes influence the survival of prostate cancer patients with bone metastasis at initial diagnosis

por Tsuchiya, Norihiko, Narita, Shintaro, Inoue, Takamitsu, Saito, Mitsuru, Numakura, Kazuyuki, Huang, Mingguo, Hatakeyama, Shingo, Satoh, Shigeru, Saito, Seiichi, Ohyama, Chikara, Arai, Yoichi, Ogawa, Osamu, Habuchi, Tomonori
Publicado 2013

The impact of obesity and adiponectin signaling in patients with renal cell carcinoma: A potential mechanism for the “obesity paradox”

por Ito, Ryuichi, Narita, Shintaro, Huang, Mingguo, Nara, Taketoshi, Numakura, Kazuyuki, Takayama, Koichiro, Tsuruta, Hiroshi, Maeno, Atsushi, Saito, Mitsuru, Inoue, Takamitsu, Tsuchiya, Norihiko, Satoh, Shigeru, Habuchi, Tomonori
Publicado 2017

Increased fatty acyl saturation of phosphatidylinositol phosphates in prostate cancer progression

por Koizumi, Atsushi, Narita, Shintaro, Nakanishi, Hiroki, Ishikawa, Masaki, Eguchi, Satoshi, Kimura, Hirotaka, Takasuga, Shunsuke, Huang, Mingguo, Inoue, Takamitsu, Sasaki, Junko, Yoshioka, Toshiaki, Habuchi, Tomonori, Sasaki, Takehiko
Publicado 2019

Prognostic value of plasminogen activator inhibitor‐1 in biomarker exploration using multiplex immunoassay in patients with metastatic renal cell carcinoma treated with axitinib

por Honma, Naoko, Inoue, Takamitsu, Tsuchiya, Norihiko, Koizumi, Atsushi, Yamamoto, Ryohei, Nara, Taketoshi, Kanda, Sohei, Huang, Mingguo, Numakura, Kazuyuki, Saito, Mitsuru, Narita, Shintaro, Satoh, Shigeru, Habuchi, Tomonori
Publicado 2020

Altering phosphoinositides in high‐fat diet‐associated prostate tumor xenograft growth

por Huang, Mingguo, Koizumi, Atsushi, Narita, Shintaro, Nakanishi, Hiroki, Sato, Hiromi, Kashima, Soki, Nara, Taketoshi, Kanda, Sohei, Numakura, Kazuyuki, Saito, Mitsuru, Satoh, Shigeru, Nanjo, Hiroshi, Sasaki, Takehiko, Habuchi, Tomonori
Publicado 2021

Clinical implications of pharmacokinetics of sunitinib malate and N-desethyl-sunitinib plasma concentrations for treatment outcome in metastatic renal cell carcinoma patients

por Numakura, Kazuyuki, Fujiyama, Nobuhiro, Takahashi, Makoto, Igarashi, Ryoma, Tsuruta, Hiroshi, Maeno, Atsushi, Huang, Mingguo, Saito, Mitsuru, Narita, Shintaro, Inoue, Takamitsu, Satoh, Shigeru, Tsuchiya, Norihiko, Niioka, Takenori, Miura, Masatomo, Habuchi, Tomonori
Publicado 2018